News
DCOY
1.110
+0.91%
0.010
Weekly Report: what happened at DCOY last week (1102-1106)?
Weekly Report · 1d ago
Weekly Report: what happened at DCOY last week (1026-1030)?
Weekly Report · 11/02 09:29
'Congo Ebola Cases Top 10,000 as Violence Hits Health Workers' - Bloomberg
Benzinga · 10/27 12:39
Weekly Report: what happened at DCOY last week (1019-1023)?
Weekly Report · 10/26 09:28
Weekly Report: what happened at DCOY last week (1012-1016)?
Weekly Report · 10/19 09:29
Weekly Report: what happened at DCOY last week (1005-1009)?
Weekly Report · 10/12 09:30
Decoy Therapeutics Files Prospectus Related To The Resale Of Up To 2,368,868 Common Shares
Benzinga · 10/07 21:07
Decoy Therapeutics registers to sell 2.37M shares of common stock for holders
TipRanks · 10/07 21:05
Weekly Report: what happened at DCOY last week (0928-1002)?
Weekly Report · 10/05 09:30
Decoy Therapeutics Reports Preclinical Data For Weekly Intranasal DCOY-CoV
NASDAQ · 09/29 12:15
Decoy Therapeutics’ human coronaviruses candidate shows positive PK data
TipRanks · 09/29 11:41
Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program
PR Newswire · 09/29 11:30
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 09/28 17:06
Weekly Report: what happened at DCOY last week (0921-0925)?
Weekly Report · 09/28 09:29
Decoy Therapeutics Inducement Warrants Boost Near-Term Liquidity
TipRanks · 09/23 21:31
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 09/23 17:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 09/23 12:06
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 09/23 08:27
Press Release: Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
Dow Jones · 09/22 22:14
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/22 21:06
More
Webull provides a variety of real-time DCOY stock news. You can receive the latest news about DECOY THERAPEUTICS INC through multiple platforms. This information may help you make smarter investment decisions.
About DCOY
Decoy Therapeutics Inc., formerly Salarius Pharmaceuticals, Inc., is a preclinical-stage biotechnology company that is leveraging machine learning and artificial intelligence (AI) tools alongside high-speed synthesis techniques to design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.